GCP
HRMY icon

GSA Capital Partners’s Harmony Biosciences HRMY Stock Holding History

GSA Capital Partners’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-45,073
Closed -$1.26M – 1928
2026
Q1 		$1.26M Buy
+45,073
New +$1.48M 0.08% 360
2025
Q2 		– Sell
-20,722
Closed -$688K – 1912
2025
Q1 		$688K Buy
+20,722
New +$743K 0.06% 577
2024
Q4 		– Sell
-5,873
Closed -$235K – 1776
2024
Q3 		$235K Buy
+5,873
New +$206K 0.02% 1348
2023
Q4 		– Sell
-12,898
Closed -$423K – 1681
2023
Q3 		$423K Buy
12,898
+6,287
+95% +$218K 0.04% 895
2023
Q2 		$233K Sell
6,611
-42,151
-86% -$1.46M 0.02% 1184
2023
Q1 		$1.59M Buy
48,762
+19,618
+67% +$893K 0.16% 124
2022
Q4 		$1.61M Buy
29,144
+8,292
+40% +$456K 0.2% 52
2022
Q3 		$924K Buy
20,852
+16,045
+334% +$783K 0.12% 193
2022
Q2 		$234K Sell
4,807
-1,793
-27% -$80.7K 0.04% 975
2022
Q1 		$321K Buy
6,600
+1,563
+31% +$63.7K 0.04% 846
2021
Q4 		$215K Buy
+5,037
New +$201K 0.03% 1161

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's HRMY Position: Q2 2026 in Review

GSA Capital Partners sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 45,073 shares — an estimated $1.26M sold.

GSA Capital Partners first reported a position in HRMY in Q4 2021 and held it in 11 quarters. The position peaked at $1.61M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • GSA Capital Partners reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 45,073 Harmony Biosciences shares in Q2 2026, an estimated $1.26M.
  • GSA Capital Partners first reported a position in Harmony Biosciences in Q4 2021 and held it in 11 quarters.
  • GSA Capital Partners's Harmony Biosciences position peaked at $1.61M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.